Health Care Inc.: STAT investigates hospital infections reporting
This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here. ~*~*~Don’t talk to…
aTyr Pharma’s Phase 3 Sarcoidosis Drug Misses Primary Endpoint
aTyr Pharma (Nasdaq: ATYR) announced topline results from its Phase…
How a change in FDA guidance might revolutionise MASH drug development
Transformative new shifts have taken place in the last month in the metabolic dysfunction-associated steatohepatitis (MASH) therapy space,…
Trump tax bill, ACA, Medicare Advantage
Tara Bannow covers hospitals, providers, and insurers. You can reach Tara on Signal at tarabannow.70. This is the…
Health care CEO salaries, UnitedHealth’s busy week
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
Join Sept. 18 with George Church and this year’s top biotech startups
I asked AI the othÂer day how many biotechs have been co-foundÂed by HarÂvard’s George Church. About 50…
Medicare Advantage research machine, A big home health deal
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
Health Care Inc.: MAGA backs Medicare, faux drug price transparency
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
Medicare Savings Programs face cut, hospitals and insurers report Q2 results
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
Sarepta Therapeutics’ Elevidys faces ‘arduous’ path back to market
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
GSK’s blood cancer drug Blenrep hits setback with FDA advisers
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
FDA focuses attention on rejected drug decisions
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…